UK markets closed

Nu-Med Plus, Inc. (NUMD)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0850+0.0181 (+27.06%)
At close: 03:51PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.10M
Enterprise value 7.19M
Trailing P/E 2.46
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA -59.70

Trading information

Stock price history

Beta (5Y monthly) 0.96
52-week change 3553.85%
S&P500 52-week change 322.38%
52-week high 30.0900
52-week low 30.0116
50-day moving average 30.0557
200-day moving average 30.0323

Share statistics

Avg vol (3-month) 348.32k
Avg vol (10-day) 333.96k
Shares outstanding 583.55M
Implied shares outstanding 683.55M
Float 845.92M
% held by insiders 145.04%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-162.00%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -118.26k
Net income avi to common (ttm)-125.53k
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.81k
Total cash per share (mrq)0
Total debt (mrq)100k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.08
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-66.39k
Levered free cash flow (ttm)-19.32k